# OnCo record nct06120491 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06120491/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06120491", "NCT06120491" ;
  schema:name "Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents"@en ;
  schema:alternateName "EvoPAR-Prostate01"@en ;
  schema:description "A phase 3 trial testing Saruparib in prostate cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06120491/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06120491> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-11-21" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mhspc/> ;
  onco:drugs <https://onco.cc/drugs/saruparib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .
